Sonnet BioTherapeutics
+$0.0044 (+1.60%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SONN and other ETFs, options, and stocks.
About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.
CEO
Pankaj Mohan
Employees
9
Headquarters
Princeton, New Jersey
Founded
2011
SONN Key Statistics
Market cap
16.96M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.37M
High today
$0.295
Low today
$0.27
Open price
$0.2712
Volume
733.62K
52 Week high
$2.07
52 Week low
$0.228
SONN Earnings
-$4.73
-$3.15
-$1.58
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
Expected Aug 15, Pre-Market